Neogen Chemicals Limited has informed the Exchange about Approval of Audited Financial Results (Standalone and Consolidated) of the Company Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2026 and Asset cover certificate, recommendation of final dividend, Amendments to 'the Code for prevention of insider trading in the securities of Neogen Chemicals Limited', Details of Outstanding Qualified Borrowings and Incremental Qualified Borrowings for F.Y. 2025-26 and Other regulation 30 announcement.

Neogen Chemicals reported standalone revenue of Rs 855.49 crore for FY2026, up 10.6% from Rs 773.65 crore in FY2025. Profit after tax stood at Rs 46.96 crore versus Rs 48.41 crore in the prior year, showing a slight decline of about 3%. The auditor issued an unmodified (clean) opinion on the financial results. A final dividend of Re. 1 per equity share was recommended for FY2025-26, subject to shareholder approval. The company also disclosed changes in project timelines for its wholly-owned subsidiary Neogen Ionics Limited, with the Dahej and Pakhajan projects now scheduled for completion in February and March 2027 respectively, due to technology changeover and additional localization capex. The outstanding insurance claim receivable from the March 2025 Dahej fire incident stands at Rs 188.96 crore.